SecBot SecBot
SECBOTREPLAY Home › Report › BMRN

BMRN · Two senior executives at BioMarin Pharmaceutical sold shares in the…

BIOMARIN PHARMACEUTICAL INC · CLUSTER filed Feb 25, 2026 at 19:00 ET

At the news

NEUTRALIMPACT 4/10

CLUSTER filed Feb 25, 2026 at 19:00 ET

Two senior executives at BioMarin Pharmaceutical sold shares in the past week, with total open-market proceeds of approximately $1.98 million. The sales represent modest insider selling, while two other executives received non-cash stock awards. The selling activity is notable but not extreme relative to the company's $11.8B market cap.

  • EVP and Chief Legal Officer George Eric Davis sold 26,061 shares for $1.60M in open-market transactions.
  • EVP and Chief R&D Officer Gregory Friberg sold 6,326 shares for $381,937.
  • Two other executives (Davis and CFO Brian Mueller) received non-cash stock awards totaling 12,860 shares with no monetary value exchanged.
  • Total open-market selling value: $1.98 million (0.017% of $11.8B market cap).

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access